Apta-1   Click here for help

GtoPdb Ligand ID: 13556

Immunopharmacology Ligand Antimalarial Ligand
Compound class: Nucleic acid
Comment: Apta-1 is a 90-mer RNA aptamer that was originally designed to bind to a conserved region of the Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as a mechanism to disrupt infectivity [1]. It contains 2'-OH RNA purine nucleotides and 2'-fluoro pyrimidine nucleotides (marked as 'f' in the sequence provided here). Apta-1 was also reported to bind to the heparin-binding exosite II of thrombin, which drives significant inhibition of protease-activated receptors PAR1 and PAR4 platelet signaling and it exhibits systemic anti-inflammatory effects [4]. Due to this latter activity, Apta-1 was repositioned as a novel approach for the treatment of sepsis and septic shock.
COVID-19:Apta-1 was evaluated for experimental anti-inflammatory action in coronavirus-induced acute lung injury [5].
No information available.
Summary of Clinical Use Click here for help
Apta-1 was repositioned as a candidate tor the treatment of sepsis, due to its anti-inflammatory, anti-thrombotic and immunomodulating properties. It was proposed that Apta-1 might ameliorate multi-organ failure driven by systemic inflammation. A first-in-human (FIH) study was completed in 2024 (UK clinical trial ISRCTN15455814).